IP Library › Granted Patent US 11,186,625
Granted Patent B2
US 11,186,625 · App. 16/996,293 · Granted Nov 30, 2021

Anti-VEGF protein compositions and methods for producing the same

Inventors: Shunhai Wang (Ossining, NY); Ning Li (New Canaan, CT); Hunter Chen (New York, NY); Amardeep Singh Bhupender Bhalla (Montvale, NJ)
Assignee: Regeneran Pharmaceuticals, Inc.
C07K14/71A61K38/1866C07K1/113C07K1/16C07K1/18C07K1/22C07K1/36C07K16/22C07K16/283C12N5/0018C12N5/0031C12N15/66C12P21/02C12P21/06G01N30/80C07K2317/622C07K2319/30C07K2319/33C12N2800/10G01N2030/027
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,186,625
App. No.
16/996,293
Granted
Nov 30, 2021
Kind
B2
Abstract

The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.

Claims (3)

1. A composition comprising oxo-aflibercept, wherein one or more amino acid residues of aflibercept is oxidized and wherein said one or more amino acid residues is histidine and/or tryptophan.

2. The composition of claim 1 , wherein said oxo-aflibercept is enzymatically digested resulting in one or more oligopeptides, and wherein said one or more oligopeptides is selected from the group consisting of: SEQ ID NO. 17, SEQ ID NO. 18, SEQ ID NO. 19, SEQ ID NO. 20, SEQ ID NO. 21, SEQ ID NO. 22, SEQ ID NO. 23, SEQ ID NO. 28, SEQ ID NO. 29, SEQ ID NO. 30, SEQ ID NO. 31, SEQ ID NO. 32 and combinations thereof.

3. The composition of claim 2 , wherein said enzymatic digestion is performed using trypsin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2020
From: WANG, SHUNHAI; LI, NING; CHEN, HUNTER; BHUPENDER BHALLA, AMARDEEP SINGH
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 054137/0400 →
Continuity (3)
Provisional Application 63065012 · Aug 13, 2020
Provisional Application 62944635 · Dec 6, 2019
Related Publication 20210171605A1 · Jun 10, 2021
Cited By (2)
US 12,240,888 US 12,540,345